Nafamostat Mesylate-impurities | Pharmaffiliates

Nafamostat Mesylate

Nafamostat mesylate, a synthetic serine protease inhibitor, it is a short-acting anticoagulant, and is also used for the treatment of pancreatitis and, It has been used in trials studying the prevention of Liver Transplantation and Postreperfusion Syndrome. Reference standards of Nafamostat Mesylate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Nafamostat Mesylate - API Standards 
    [catalogue_number] => PA 14 1310000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 539.58
    [form] => C21H25N5O8S2
    [cas] => 82956-11-4
    [pslug] => 82956-11-4-nafamostat-mesylate-pa141310000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 14 1310000

Nafamostat Mesylate - API Standards


  • Catalogue No.:PA 14 1310000

  • CAS :

    82956-11-4

  • Molecular Formula : C21H25N5O8S2

  • Molecular Weight : 539.58